Companies: 10,795·Total market cap: $144.5T
Alterity Therapeutics Limited

Alterity Therapeutics Limited

ATHENASDAQHealthcare● Active
$4.35
+$0.44(+11.11%)
Market Cap$39432154
P/E Ratio—
52W High$7
52W Low$2.66
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Alterity Therapeutics Limited (ATHE) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001131343 · ATHE · NASDAQ · as of Jun 9, 2026

Filing snapshot

1,003+
Total Filings
6-K
Latest Form
2026-06-09
Most Recent
2003
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001131343 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2025-08-29
Fiscal Year End
Aug 29, 2025
Accession No.
0001213900-25-082027
Primary Document
ea0254438-20f_alterity.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001131343 · Accession 0001213900-25-082027

Latest Key Filings

6-KQuarterly Report
FORM 6-K
2026-06-09
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-06-09
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-06-04
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-06-03
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-29
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-19
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-12
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-11
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-07
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-30
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-30
View
3Initial Statement of Beneficial Ownership
PRIMARY DOCUMENT
2026-04-29
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-29
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-27
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-27
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-22
View
Showing 1–15 of 1003 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001131343  |  Exchange: NASDAQ · Healthcare

Alterity Therapeutics Limited (NASDAQ: ATHE) has submitted 1,003+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2003. As a Healthcare sector company with CIK 0001131343, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Alterity Therapeutics Limited's most comprehensive regulatory disclosure. The most recent Alterity Therapeutics Limited 10-K was filed on 2025-08-29 for fiscal year ending 2025. Historical ATHE 10-K annual reports are available from 2006 through 2025.

Investors researching Alterity Therapeutics Limited SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
MAIA SEC Filings →GBIO SEC Filings →ANVS SEC Filings →MURA SEC Filings →BTAI SEC Filings →IGC SEC Filings →NNVC SEC Filings →DYAI SEC Filings →
→ ATHE Financials→ ATHE Earnings→ ATHE Insider Trades

Frequently Asked Questions

ATHE SEC Filings · 8 questions

Alterity Therapeutics Limited (ATHE) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,003+ filings and access original documents at no cost. Alterity Therapeutics Limited's CIK is 0001131343.

ATHE SEC filingsAlterity Therapeutics Limited SEC documentsfind ATHE 10-K